MPM Capital
Overview
MPM Capital caters to the healthcare sector with seed, early, and later stage ventures, and private equity investments.
Investment Focus
- Late-stage drug development
- Biopharmaceutical innovation
- Medical device commercialization
- Addressing unmet medical needs
- Improving patient outcomes
- Collaborations with pharmaceutical, biotechnology, and medical technology companies
- Advancing critical path products to market
- Generating attractive, market-unrelated returns at lower risk
- Funding late-stage development of innovative core products
- Capturing value directly from funded products
- Maintaining a high success rate in clinical trials
- Supporting the development of novel medicines in immunology and inflammation
- Providing strategic funding and operational expertise
- Accelerating the development and commercialization of innovative therapies
- Operating globally across multiple therapeutic areas
- Managing substantial assets under management
- Launching and supporting clinical-stage drug development companies
- Investing in companies with significant unmet medical needs
- Advancing therapies with potential to improve patient outcomes
- Maintaining a strong track record in the life sciences sector
Portfolio Companies
Reach MPM Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about MPM Capital
What sectors does MPM Capital invest in?
MPM Capital invests in Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Cambridge, Massachusetts, United States. MPM Capital is listed as a vc in the ConnectSafely investor database.
What stage does MPM Capital invest at?
MPM Capital backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 50M - 1B.
Which regions does MPM Capital invest in?
MPM Capital invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has MPM Capital invested in?
MPM Capital's portfolio includes Moderna, Alnylam Pharmaceuticals, Anthos Therapeutics, Inc. and Uniquity Bio.
How do I contact MPM Capital?
MPM Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
